These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
316 related items for PubMed ID: 20650329
1. Central noradrenergic lesion induced by DSP-4 impairs the acquisition of avoidance reactions and prevents molecular changes in the amygdala. Radwanska K, Nikolaev E, Kaczmarek L. Neurobiol Learn Mem; 2010 Oct; 94(3):303-11. PubMed ID: 20650329 [Abstract] [Full Text] [Related]
2. Galanin-mediated anxiolytic effect in rat central amygdala is not a result of corelease from noradrenergic terminals. Barrera G, Hernandez A, Poulin JF, Laforest S, Drolet G, Morilak DA. Synapse; 2006 Jan; 59(1):27-40. PubMed ID: 16237681 [Abstract] [Full Text] [Related]
3. Enhancement of active shuttle avoidance response by the NO-cGMP-PKG activator YC-1. Chien WL, Liang KC, Fu WM. Eur J Pharmacol; 2008 Aug 20; 590(1-3):233-40. PubMed ID: 18590724 [Abstract] [Full Text] [Related]
10. Electroencephalographic study of the effect of neurotoxin DSP-4 in iron model of chronic focal epilepsy. Sharma V, Singh R. Indian J Exp Biol; 1999 May 01; 37(5):468-75. PubMed ID: 10492619 [Abstract] [Full Text] [Related]
11. The response of noradrenergic axons to systemically administered DSP-4 in the rat: an immunohistochemical study using antibodies to noradrenaline and dopamine-beta-hydroxylase. Fritschy JM, Geffard M, Grzanna R. J Chem Neuroanat; 1990 May 01; 3(4):309-21. PubMed ID: 2204356 [Abstract] [Full Text] [Related]
13. Effect of DSP4 and desipramine in the sensorial and affective component of neuropathic pain in rats. Bravo L, Mico JA, Rey-Brea R, Camarena-Delgado C, Berrocoso E. Prog Neuropsychopharmacol Biol Psychiatry; 2016 Oct 03; 70():57-67. PubMed ID: 27181607 [Abstract] [Full Text] [Related]